Cite
MLA Citation
S Halder et al.. “P071 Supporting extrapolation of indications for ABP 501, the first adalimumab biosimilar: focus on Crohn's disease.” Journal of Crohn's and colitis, vol. 13, n.d., p. S121. http://access.bl.uk/ark:/81055/vdc_100094064212.0x00000b